All articles by  

  1. Aspen to acquire remaining rights to AstraZeneca’s anaesthetic medicines

    Aspen Global Incorporated (AGI) has entered an agreement to acquire all the remaining rights to AstraZeneca’s established anaesthetic treatments for…
    Read More…

    17 Sep
  2. Amgen and Allergan’s anti-cancer biosimilar Mvasi receives FDA approval

    The US Food and Drug Administration (FDA) has approved Mvasi (bevacizumab-awwb) for the treatment of five types of cancer. Co-developed…
    Read More…

    17 Sep
Close
Close
Close

Go Top